Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner
Authors:
- 4 June 2012
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 224 (2) , 289-301
Abstract
Rationale Mechanisms that mediate age differences during nicotine withdrawal are unclear. Objective This study compared kappa-opioid receptor (KOR) activation in naïve and nicotine-treated adolescent and adult rats using behavioral and neurochemical approaches to study withdrawal. Methods The behavioral models used to assess withdrawal included conditioned place and elevated plus maze procedures. Deficits in dopamine transmission in the nucleus accumbens (NAcc) were examined using microdialysis procedures. Lastly, the effects of KOR stimulation and blockade on physical signs produced upon removal of nicotine were examined in adults. Results Nicotine-treated adults displayed a robust aversion to an environment paired with a KOR agonist versus naïve adults. Neither of the adolescent groups displayed a place aversion. KOR activation produced an increase in anxiety-like behavior that was highest in nicotine-treated adults versus all other groups. KOR activation produced a decrease in NAcc dopamine that was largest in nicotine-treated adults versus all other groups. Lastly, KOR activation facilitated physical signs of withdrawal upon removal of nicotine and KOR blockade reduced this effect. Conclusion Chronic nicotine enhanced the affective, anxiogenic, and neurochemical effects produced by KOR activation in adult rats. Our data suggest that chronic nicotine elicits an increase in KOR function, and this may contribute to nicotine withdrawal since KOR activation facilitated and KOR blockade prevented withdrawal signs upon removal of nicotine. Given that chronic nicotine facilitated the neurochemical effects of KOR agonists in adults but not in adolescents, it is suggested that KOR regulation of mesolimbic dopamine may contribute to age differences in nicotine withdrawal.Keywords
This publication has 53 references indexed in Scilit:
- Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependenceAlcohol, 2012
- Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid systemNeuroscience & Biobehavioral Reviews, 2010
- The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abusePsychopharmacology, 2010
- Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mousePsychopharmacology, 2010
- The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsBrain Research, 2010
- kappa-Opioid receptor signaling and brain reward functionBrain Research Reviews, 2009
- Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male ratsSynapse, 2009
- A psychobiological framework of the substrates that mediate nicotine use during adolescenceNeuropharmacology, 2009
- Biological substrates of reward and aversion: A nucleus accumbens activity hypothesisNeuropharmacology, 2009
- Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanismEuropean Journal of Pharmacology, 2007